Treprostinil Injection
Product Images NDC 0781-3425

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Treprostinil (NDC 0781-3425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Treprostinil 01)

Chemical structure of treprostinil, the active ingredient in Treprostinil injection by Sandoz Inc. The diagram shows the molecular structure including hydroxyl groups and a side chain, representing the compound used for intravenous or subcutaneous administration.*

FDA Label Image

Figure-1 (Treprostinil 02)

A Kaplan-Meier curve showing the percentage of subjects without a clinical deterioration event over a 60-day study. Two treatment groups are compared: Treprostinil Injection (solid line) and Placebo (dashed line). The graph illustrates a higher percentage without deterioration in the Treprostinil group versus Placebo, with a p-value of 0.000228 indicating statistical significance.*

FDA Label Image

20 mg-carton (Image 01)

Packaging label for Treprostinil Injection 20 mg/20 mL (1 mg/mL) by Sandoz Inc. The label indicates a 20 mL multi-dose vial for subcutaneous and intravenous infusion. It includes content details, storage instructions (20° to 25°C), and ingredient information for treprostinil injection.*

FDA Label Image

50mg-carton (Image 02)

Packaging label for Treprostinil Injection 50 mg/20 mL (2.5 mg/mL) multi-dose vial by Sandoz Inc. The label indicates a 20 mL vial for subcutaneous and intravenous infusion, includes storage instructions, inactive ingredients, and states it is Rx only.*

FDA Label Image

100mg-carton (Image 03)

Packaging label for Treprostinil Injection 100 mg/20 mL (5 mg/mL) in a 20 mL multi-dose vial by Sandoz Inc. The label indicates that the injection is for subcutaneous and intravenous infusion, contains 5 mg treprostinil per mL with additional ingredients for pH adjustment, and must be stored at 20° to 25°C (68° to 77°F). The label includes NDC 0781-3427-80 and directions to see the package insert for usual dosage.*

FDA Label Image

200mg-carton (Image 04)

Packaging label for Treprostinil Injection 200 mg/20 mL (10 mg/mL) in a 20 mL multi-dose vial. The label indicates it is for subcutaneous and intravenous infusion, with storage instructions and contents details. Distributed by Sandoz Inc.*

FDA Label Image

Diluent-carton (Treprostinil 07)

Packaging label for Sterile Diluent for Treprostinil Injection by Sandoz Inc. The label specifies a 1 x 50 mL single-dose vial for intravenous infusion of treprostinil. It includes storage instructions at 20° to 25°C and standard drug handling notes such as discarding unused portions. The label features drug identification, manufacturer details, and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.